Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion
Source: SeekingAlpha
2026-03-03 19:33:17 ET
More on Cumberland Pharmaceuticals
- Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript
- Seeking Alpha’s Quant Rating on Cumberland Pharmaceuticals
- Financial information for Cumberland Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion
Cumberland Pharmaceuticals Inc.
NASDAQ: CPIX
CPIX Trading
-2.75% G/L:
$3.365 Last:
35,037 Volume:
$3.44 Open:
CPIX Latest News
March 03, 2026 05:00:00 pm
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
CPIX Stock Data
$56,835,183
8,248,580
40.62%
6
N/A
Pharmaceuticals
Healthcare
US
Nashville
